NSCLC(non-small cell lung cancer) is a common lung cancer (85%) in the world.The Pinpoint Dx Lung Assay targets these patients and diagnose the effect to chemotherapy. The Pinpoint Dx Lung Assay, launched in late January concurrent with th…